Your prediction
Novozymes A/S B Stock
There is an upward development for Novozymes A/S B compared to yesterday, with an increase of €0.58 (1.070%).
Our community identified positive and negative aspects for Novozymes A/S B stock for the coming years. 1 users see the criterium "Return on equity" as a plus for the Novozymes A/S B stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Novozymes A/S B in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novozymes A/S B vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novozymes A/S B | 1.070% | 0.884% | 2.164% | -0.073% | -0.073% | 15.552% | 16.042% |
| Solvay S.A. A | 0.740% | 1.788% | -0.727% | -11.068% | -11.068% | -71.278% | -72.014% |
| Eastman Chemical Co. | 0.110% | 2.151% | 1.196% | -37.842% | -37.842% | -29.358% | -32.937% |
| Celanese Corp. A | 0.800% | 2.476% | 1.364% | -44.244% | -44.244% | -62.263% | -65.314% |
